Chemical Compound Review:
SL-1846 7-hydroxy-8-methoxy-7-[2- methyl-3-(3...
Synonyms:
LS-99627, AC1L1I25, C16H24O5
- Chlovalicin, a new cytocidal antibiotic produced by Sporothrix sp. FO-4649. I. Taxonomy, fermentation, isolation and biological activities. Hayashi, M., Kim, Y.P., Takamatsu, S., Preeprame, S., Komiya, T., Masuma, R., Tanaka, H., Komiyama, K., Omura, S. J. Antibiot. (1996)
- Enhanced toxicity of the immunosuppressant ovalicin upon application to the skin. Stähelin, H. Experientia (1988)
- Investigations into microsporidian methionine aminopeptidase type 2: a therapeutic target for microsporidiosis. Zhang, H., Huang, H., Cali, A., Takvorian, P.M., Feng, X., Zhou, G., Weiss, L.M. Folia Parasitol. (2005)
- Protacs: chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation. Sakamoto, K.M., Kim, K.B., Kumagai, A., Mercurio, F., Crews, C.M., Deshaies, R.J. Proc. Natl. Acad. Sci. U.S.A. (2001)
- Molecular recognition of angiogenesis inhibitors fumagillin and ovalicin by methionine aminopeptidase 2. Griffith, E.C., Su, Z., Niwayama, S., Ramsay, C.A., Chang, Y.H., Liu, J.O. Proc. Natl. Acad. Sci. U.S.A. (1998)
- A single amino acid residue defines the difference in ovalicin sensitivity between type I and II methionine aminopeptidases. Brdlik, C.M., Crews, C.M. J. Biol. Chem. (2004)
- Letter: Application of carbon-13 magnetic resonance to isoprenoid biosynthesis. I. Ovalicin. Cane, D.E., Levin, R.H. J. Am. Chem. Soc. (1975)
- Structural basis for the functional differences between type I and type II human methionine aminopeptidases. Addlagatta, A., Hu, X., Liu, J.O., Matthews, B.W. Biochemistry (2005)
- QSAR of the inhibition of angiogenesis by TNP-470 and ovalicin analogues: another example of an allosteric interaction. Mekapati, S.B., Hansch, C. Bioorg. Med. Chem. (2001)
- On the mode of action of the immunosuppressive sesquiterpene ovalicin. Zimmermann, W.A., Hartmann, G.R. Eur. J. Biochem. (1981)
- Selective inhibition of amino-terminal methionine processing by TNP-470 and ovalicin in endothelial cells. Turk, B.E., Griffith, E.C., Wolf, S., Biemann, K., Chang, Y.H., Liu, J.O. Chem. Biol. (1999)
- Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin. Griffith, E.C., Su, Z., Turk, B.E., Chen, S., Chang, Y.H., Wu, Z., Biemann, K., Liu, J.O. Chem. Biol. (1997)
- Methionine aminopeptidase 2 is a new target for the metastasis-associated protein, S100A4. Endo, H., Takenaga, K., Kanno, T., Satoh, H., Mori, S. J. Biol. Chem. (2002)
- Development of Protacs to target cancer-promoting proteins for ubiquitination and degradation. Sakamoto, K.M., Kim, K.B., Verma, R., Ransick, A., Stein, B., Crews, C.M., Deshaies, R.J. Mol. Cell Proteomics (2003)
- Antimicrosporidial activities of fumagillin, TNP-470, ovalicin, and ovalicin derivatives in vitro and in vivo. Didier, P.J., Phillips, J.N., Kuebler, D.J., Nasr, M., Brindley, P.J., Stovall, M.E., Bowers, L.C., Didier, E.S. Antimicrob. Agents Chemother. (2006)
- Synthetic analogues of TNP-470 and ovalicin reveal a common molecular basis for inhibition of angiogenesis and immunosuppression. Turk, B.E., Su, Z., Liu, J.O. Bioorg. Med. Chem. (1998)